fashion -WSS

fashion

author：hotspot 2025-10-01 21:36:14 - browse：42323

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Readout LOUD podcast: ESMO highlights & Roivant's big deal

WSS

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Medicare proceeds with plan to claw back hospital funds

Poor hospice wound care hurts patients and families

Medicare proceeds with plan to claw back hospital funds

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

CRISPR pioneers react to Casgevy, first gene

23andMe had bad news about my health. I wish a person had delivered it

Prime Medicine says its gene editing passes test in monkeys

Walensky prepares to leave CDC — and Congress — behind

Weight loss drug costs may need more research, senator suggests

Medicare proposal to cover medical devices draws a mixed reaction

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Walensky prepares to leave CDC — and Congress — behind

Does good food count as health care? Study aims to find out

Wikipedia

Hospitals look to new technology to keep health care workers safe

NYU radiologists take on the challenge of expensive MRI machines

Prime Medicine says its gene editing passes test in monkeys

Prime Medicine says its gene editing passes test in monkeys

Weight loss drug costs may need more research, senator suggests

All of Us, NIH's precision medicine initiative, gets a big boost

focus

hotspot

leisure time

entertainment